Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Si-Guan point acupuncture combined with Duragesic for moderate to severe cancer pain
ChiCTR-IOR-14005494Phase 3Not yet recruiting
- Sponsor
- First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Start
- Dec 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of fentanyl in cancer pain (2 arms), sponsored by First Affiliated Hospital of Guangzhou University of Chinese Medicine. Primary endpoint: Numeric rating scale. Planned start Dec 2014; status: not yet recruiting.
02
Drugs
fentanyl
03
Conditions
cancer pain
Beyond the preview
Go deeper on ChiCTR-IOR-14005494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IOR-14005494.